Format

Send to

Choose Destination
J Am Acad Dermatol. 2019 Apr;80(4):1029-1072. doi: 10.1016/j.jaad.2018.11.057. Epub 2019 Feb 13.

Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics.

Author information

1
Baylor Scott and White, Dallas, Texas.
2
University of Connecticut, Farmington, Connecticut; Probity Medical Research, Waterloo, Ontario, Canada.
3
University of Pittsburgh, Pittsburgh, Pennsylvania.
4
University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
5
Emory University School of Medicine, Atlanta, Georgia.
6
University of Southern California, Los Angeles, San Francisco.
7
University of Alabama, Birmingham, Alabama.
8
University of California, San Francisco School of Medicine, Department of Dermatology, San Francisco, California.
9
Mayo Clinic, Rochester, Minnesota.
10
University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
11
Medical College of Wisconsin, Milwaukee, Wisconsin.
12
Department of Dermatology, Icahn School of Medicine at Mt. Sinai, New York.
13
University of California San Diego, San Diego, California.
14
National Psoriasis Foundation, Portland, Oregon.
15
University Hospitals Cleveland Medical Center, Cleveland, Ohio.
16
Massachusetts General Hospital, Boston, Massachusetts.
17
Central Dermatology, St. Louis, Missouri.
18
Department of Dermatology, Henry Ford Hospital, Detroit, Michigan.
19
National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.
20
Northwestern University Feinberg School of Medicine, Chicago, Illinois.
21
Dermatology and Skin Surgery, Sumter, South Carolina.
22
Colorado Permanente Medical Group, Centennial, Colorado.
23
San Antonio Uniformed Services Health Education Consortium, Joint-Base San Antonio.
24
Dermatology Research and Education Foundation, Irvine, California.
25
American Academy of Dermatology, Rosemont, Illinois. Electronic address: vhariharan@aad.org.

Abstract

Psoriasis is a chronic, inflammatory multisystem disease that affects up to 3.2% of the US population. This guideline addresses important clinical questions that arise in psoriasis management and care, providing recommendations based on the available evidence. The treatment of psoriasis with biologic agents will be reviewed, emphasizing treatment recommendations and the role of the dermatologist in monitoring and educating patients regarding benefits as well as associated risks.

KEYWORDS:

biologic agents; clinical guidelines for psoriasis; dermatology; guidelines; monoclonal antibodies; psoriasis; skin disease

PMID:
30772098
DOI:
10.1016/j.jaad.2018.11.057
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center